OPTIMISE-CKD Study_current Clinical Landscape in Spain

NCT06614712 · clinicaltrials.gov ↗

COMPLETED

Status

91628

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Disease

Interventions

OTHER: Pre-pricing & reimbursement, incident renal disease cohort (study observation period 2020- 2024)
OTHER: Post-pricing & reimbursement, incident renal disease cohort (study observation period 2023-2024)

Sponsor

AstraZeneca